Dr. Jennifer Graff is the National Pharmaceutical Council's (NPC) vice president of comparative effectiveness research. In this role, she leads research and policy initiatives to advance the use of evidence-based medicine to inform patient care. Her areas of focus are to encourage the generation, acceptance, and use of high-quality evidence to inform decision-making. Prior to joining NPC in 2009, Dr. Graff led strategic health economic and outcomes research activities at MedImmune and at Pfizer Pharmaceuticals. She has authored over 15 peer-reviewed articles and presents frequently on policy issues affecting the biopharmaceutical industry and serves as a merit reviewer for the Patient-Centered Outcomes Research Institute. She currently serves as an associate editor of eGEMS journal and as a governing board member of the Agency for Healthcare Research and Quality Registry of Patient Registries Web Forum. Dr. Graff holds a Doctorate of Pharmacy from the University of Nebraska Medical Center, and completed a Health Outcomes and Pharmacoeconomics fellowship at the University of Michigan.
12:30 PM–1:30 PM May 21, 2018 (US - Eastern)